Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood (Q37433170)

20 August 2017

1 reference

title

Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood (English)

1 reference

20 August 2017

Gallin JI

1

1 reference

20 August 2017

1 November 1991

1 reference

Clinical Immunology and Immunopathology

20 August 2017

1 reference

20 August 2017

61

1 reference

20 August 2017

2 Pt 2

1 reference

20 August 2017

S100-5

1 reference

Tissue destruction by neutrophils

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Current concepts: immunology. Neutrophils in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Update on chronic granulomatous diseases of childhood. Immunotherapy and potential for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

NIH conference. Recent advances in chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980044-3

7 January 2021

10.1016/S0090-1229(05)80044-3

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

1934607